nodes	percent_of_prediction	percent_of_DWPC	metapath
Gliclazide—VEGFA—Endochondral Ossification—FRZB—osteoarthritis	0.0558	0.0558	CbGpPWpGaD
Gliclazide—VEGFA—Differentiation Pathway—GDF5—osteoarthritis	0.0403	0.0403	CbGpPWpGaD
Gliclazide—VEGFA—Endochondral Ossification—SOX9—osteoarthritis	0.0306	0.0306	CbGpPWpGaD
Gliclazide—VEGFA—Beta3 integrin cell surface interactions—TGFBI—osteoarthritis	0.0279	0.0279	CbGpPWpGaD
Gliclazide—VEGFA—Endochondral Ossification—IHH—osteoarthritis	0.0272	0.0272	CbGpPWpGaD
Gliclazide—VEGFA—Endochondral Ossification—COL10A1—osteoarthritis	0.0272	0.0272	CbGpPWpGaD
Gliclazide—VEGFA—Endochondral Ossification—ADAMTS5—osteoarthritis	0.0256	0.0256	CbGpPWpGaD
Gliclazide—VEGFA—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—osteoarthritis	0.0223	0.0223	CbGpPWpGaD
Gliclazide—VEGFA—Hypertrophy Model—IL1A—osteoarthritis	0.0221	0.0221	CbGpPWpGaD
Gliclazide—VEGFA—Endochondral Ossification—ADAMTS4—osteoarthritis	0.0218	0.0218	CbGpPWpGaD
Gliclazide—VEGFA—Differentiation Pathway—TNFSF11—osteoarthritis	0.0212	0.0212	CbGpPWpGaD
Gliclazide—VEGFA—Beta1 integrin cell surface interactions—TGFBI—osteoarthritis	0.0198	0.0198	CbGpPWpGaD
Gliclazide—VEGFA—Heart Development—BMP2—osteoarthritis	0.018	0.018	CbGpPWpGaD
Gliclazide—VEGFA—Integrins in angiogenesis—COL2A1—osteoarthritis	0.0164	0.0164	CbGpPWpGaD
Gliclazide—VEGFA—Endochondral Ossification—COL2A1—osteoarthritis	0.0162	0.0162	CbGpPWpGaD
Gliclazide—VEGFA—Beta1 integrin cell surface interactions—COL2A1—osteoarthritis	0.0158	0.0158	CbGpPWpGaD
Gliclazide—VEGFA—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—osteoarthritis	0.0148	0.0148	CbGpPWpGaD
Gliclazide—VEGFA—Alpha9 beta1 integrin signaling events—FN1—osteoarthritis	0.0143	0.0143	CbGpPWpGaD
Gliclazide—VEGFA—Endochondral Ossification—MMP13—osteoarthritis	0.0138	0.0138	CbGpPWpGaD
Gliclazide—VEGFA—Oncostatin M Signaling Pathway—MMP13—osteoarthritis	0.0136	0.0136	CbGpPWpGaD
Gliclazide—VEGFA—Focal Adhesion—COMP—osteoarthritis	0.0134	0.0134	CbGpPWpGaD
Gliclazide—VEGFA—Bladder Cancer—MMP1—osteoarthritis	0.0132	0.0132	CbGpPWpGaD
Gliclazide—VEGFA—S1P1 pathway—PTGS2—osteoarthritis	0.0129	0.0129	CbGpPWpGaD
Gliclazide—VEGFA—Platelet degranulation—HSPA5—osteoarthritis	0.0104	0.0104	CbGpPWpGaD
Gliclazide—VEGFA—Response to elevated platelet cytosolic Ca2+—HSPA5—osteoarthritis	0.00992	0.00992	CbGpPWpGaD
Gliclazide—VEGFA—Platelet degranulation—TIMP1—osteoarthritis	0.00992	0.00992	CbGpPWpGaD
Gliclazide—CYP2C19—Arachidonic acid metabolism—PTGES—osteoarthritis	0.00961	0.00961	CbGpPWpGaD
Gliclazide—VEGFA—Response to elevated platelet cytosolic Ca2+—TIMP1—osteoarthritis	0.00945	0.00945	CbGpPWpGaD
Gliclazide—VEGFA—Angiogenesis—MMP9—osteoarthritis	0.0094	0.0094	CbGpPWpGaD
Gliclazide—VEGFA—Beta3 integrin cell surface interactions—FN1—osteoarthritis	0.00925	0.00925	CbGpPWpGaD
Gliclazide—VEGFA—Oncostatin M Signaling Pathway—MMP3—osteoarthritis	0.00911	0.00911	CbGpPWpGaD
Gliclazide—VEGFA—Aryl Hydrocarbon Receptor—ESR1—osteoarthritis	0.00887	0.00887	CbGpPWpGaD
Gliclazide—CYP2C9—Arachidonic acid metabolism—PTGES—osteoarthritis	0.00877	0.00877	CbGpPWpGaD
Gliclazide—VEGFA—Bladder Cancer—CXCL8—osteoarthritis	0.00846	0.00846	CbGpPWpGaD
Gliclazide—KCNJ11—Type II diabetes mellitus—TNF—osteoarthritis	0.00823	0.00823	CbGpPWpGaD
Gliclazide—VEGFA—HIF-1-alpha transcription factor network—SMAD3—osteoarthritis	0.00814	0.00814	CbGpPWpGaD
Gliclazide—VEGFA—Differentiation Pathway—IGF1—osteoarthritis	0.00742	0.00742	CbGpPWpGaD
Gliclazide—VEGFA—Allograft Rejection—IL1A—osteoarthritis	0.00737	0.00737	CbGpPWpGaD
Gliclazide—VEGFA—Oncostatin M Signaling Pathway—MMP1—osteoarthritis	0.00728	0.00728	CbGpPWpGaD
Gliclazide—VEGFA—Glypican 1 network—TGFB1—osteoarthritis	0.00726	0.00726	CbGpPWpGaD
Gliclazide—VEGFA—HIF-1-alpha transcription factor network—LEP—osteoarthritis	0.00696	0.00696	CbGpPWpGaD
Gliclazide—VEGFA—Integrins in angiogenesis—FN1—osteoarthritis	0.00681	0.00681	CbGpPWpGaD
Gliclazide—VEGFA—Focal Adhesion—COL2A1—osteoarthritis	0.00678	0.00678	CbGpPWpGaD
Gliclazide—VEGFA—Beta1 integrin cell surface interactions—FN1—osteoarthritis	0.00656	0.00656	CbGpPWpGaD
Gliclazide—VEGFA—SHP2 signaling—IGF1—osteoarthritis	0.00638	0.00638	CbGpPWpGaD
Gliclazide—VEGFA—Aryl Hydrocarbon Receptor—PTGS2—osteoarthritis	0.00636	0.00636	CbGpPWpGaD
Gliclazide—VEGFA—Integrins in angiogenesis—IGF1—osteoarthritis	0.00597	0.00597	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—IL1RN—osteoarthritis	0.00594	0.00594	CbGpPWpGaD
Gliclazide—VEGFA—Endochondral Ossification—IGF1—osteoarthritis	0.00589	0.00589	CbGpPWpGaD
Gliclazide—VEGFA—Platelet degranulation—FN1—osteoarthritis	0.00563	0.00563	CbGpPWpGaD
Gliclazide—VEGFA—Axon guidance—COL9A2—osteoarthritis	0.00546	0.00546	CbGpPWpGaD
Gliclazide—VEGFA—Response to elevated platelet cytosolic Ca2+—FN1—osteoarthritis	0.00536	0.00536	CbGpPWpGaD
Gliclazide—VEGFA—Axon guidance—COL9A1—osteoarthritis	0.0053	0.0053	CbGpPWpGaD
Gliclazide—ABCC8—Neuronal System—CAMK2B—osteoarthritis	0.00527	0.00527	CbGpPWpGaD
Gliclazide—KCNJ11—Neuronal System—CAMK2B—osteoarthritis	0.00511	0.00511	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—CAMK2B—osteoarthritis	0.00503	0.00503	CbGpPWpGaD
Gliclazide—VEGFA—Platelet degranulation—IGF1—osteoarthritis	0.00493	0.00493	CbGpPWpGaD
Gliclazide—VEGFA—Response to elevated platelet cytosolic Ca2+—IGF1—osteoarthritis	0.0047	0.0047	CbGpPWpGaD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—HSPA5—osteoarthritis	0.00462	0.00462	CbGpPWpGaD
Gliclazide—VEGFA—Differentiation Pathway—TGFB1—osteoarthritis	0.00445	0.00445	CbGpPWpGaD
Gliclazide—VEGFA—VEGFR2 mediated cell proliferation—IL6—osteoarthritis	0.00442	0.00442	CbGpPWpGaD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—TIMP1—osteoarthritis	0.0044	0.0044	CbGpPWpGaD
Gliclazide—VEGFA—Aryl Hydrocarbon Receptor—TNF—osteoarthritis	0.0043	0.0043	CbGpPWpGaD
Gliclazide—VEGFA—Endochondral Ossification—MMP9—osteoarthritis	0.00429	0.00429	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—IL1A—osteoarthritis	0.00427	0.00427	CbGpPWpGaD
Gliclazide—VEGFA—EPH-Ephrin signaling—MMP2—osteoarthritis	0.00419	0.00419	CbGpPWpGaD
Gliclazide—VEGFA—Allograft Rejection—CXCL8—osteoarthritis	0.004	0.004	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—COL9A2—osteoarthritis	0.0039	0.0039	CbGpPWpGaD
Gliclazide—VEGFA—Allograft Rejection—IL1B—osteoarthritis	0.00384	0.00384	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—COL9A1—osteoarthritis	0.00378	0.00378	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—MMP1—osteoarthritis	0.00371	0.00371	CbGpPWpGaD
Gliclazide—ALB—Platelet degranulation—HSPA5—osteoarthritis	0.00367	0.00367	CbGpPWpGaD
Gliclazide—VEGFA—Endochondral Ossification—TGFB1—osteoarthritis	0.00353	0.00353	CbGpPWpGaD
Gliclazide—ALB—Response to elevated platelet cytosolic Ca2+—HSPA5—osteoarthritis	0.0035	0.0035	CbGpPWpGaD
Gliclazide—ALB—Platelet degranulation—TIMP1—osteoarthritis	0.0035	0.0035	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—ESR1—osteoarthritis	0.00343	0.00343	CbGpPWpGaD
Gliclazide—VEGFA—Differentiation Pathway—IL6—osteoarthritis	0.00335	0.00335	CbGpPWpGaD
Gliclazide—ALB—Response to elevated platelet cytosolic Ca2+—TIMP1—osteoarthritis	0.00333	0.00333	CbGpPWpGaD
Gliclazide—VEGFA—EPH-Ephrin signaling—MMP9—osteoarthritis	0.00315	0.00315	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—CRP—osteoarthritis	0.00308	0.00308	CbGpPWpGaD
Gliclazide—VEGFA—Allograft Rejection—TGFB1—osteoarthritis	0.00299	0.00299	CbGpPWpGaD
Gliclazide—VEGFA—Platelet degranulation—TGFB1—osteoarthritis	0.00296	0.00296	CbGpPWpGaD
Gliclazide—VEGFA—SHP2 signaling—IL6—osteoarthritis	0.00288	0.00288	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	0.00284	0.00284	CbGpPWpGaD
Gliclazide—VEGFA—Focal Adhesion—FN1—osteoarthritis	0.00282	0.00282	CbGpPWpGaD
Gliclazide—VEGFA—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoarthritis	0.00282	0.00282	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—IL1A—osteoarthritis	0.00281	0.00281	CbGpPWpGaD
Gliclazide—VEGFA—Allograft Rejection—TNF—osteoarthritis	0.00279	0.00279	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—FMOD—osteoarthritis	0.00259	0.00259	CbGpPWpGaD
Gliclazide—CYP2C19—Biological oxidations—GSTO1—osteoarthritis	0.00252	0.00252	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—FMOD—osteoarthritis	0.00251	0.00251	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—CRP—osteoarthritis	0.00251	0.00251	CbGpPWpGaD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—FN1—osteoarthritis	0.0025	0.0025	CbGpPWpGaD
Gliclazide—CYP2C19—Metapathway biotransformation—GSTO1—osteoarthritis	0.00249	0.00249	CbGpPWpGaD
Gliclazide—VEGFA—Focal Adhesion—IGF1—osteoarthritis	0.00247	0.00247	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	0.00246	0.00246	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—HSPA5—osteoarthritis	0.00238	0.00238	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—CXCL8—osteoarthritis	0.00232	0.00232	CbGpPWpGaD
Gliclazide—CYP2C9—Biological oxidations—GSTO1—osteoarthritis	0.0023	0.0023	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—TIMP1—osteoarthritis	0.00227	0.00227	CbGpPWpGaD
Gliclazide—CYP2C9—Metapathway biotransformation—GSTO1—osteoarthritis	0.00227	0.00227	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—IL1B—osteoarthritis	0.00223	0.00223	CbGpPWpGaD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—IGF1—osteoarthritis	0.00219	0.00219	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—PTGES—osteoarthritis	0.00211	0.00211	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—PTGES—osteoarthritis	0.00205	0.00205	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	0.00204	0.00204	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—CRP—osteoarthritis	0.00199	0.00199	CbGpPWpGaD
Gliclazide—ALB—Platelet degranulation—FN1—osteoarthritis	0.00199	0.00199	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—IL1B—osteoarthritis	0.00192	0.00192	CbGpPWpGaD
Gliclazide—ALB—Response to elevated platelet cytosolic Ca2+—FN1—osteoarthritis	0.00189	0.00189	CbGpPWpGaD
Gliclazide—CYP2C19—Arachidonic acid metabolism—PTGS2—osteoarthritis	0.00189	0.00189	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IHH—osteoarthritis	0.00177	0.00177	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—MCF2L—osteoarthritis	0.00177	0.00177	CbGpPWpGaD
Gliclazide—VEGFA—VEGFA-VEGFR2 Pathway—IL6—osteoarthritis	0.00176	0.00176	CbGpPWpGaD
Gliclazide—ALB—Platelet degranulation—IGF1—osteoarthritis	0.00174	0.00174	CbGpPWpGaD
Gliclazide—CYP2C9—Arachidonic acid metabolism—PTGS2—osteoarthritis	0.00172	0.00172	CbGpPWpGaD
Gliclazide—VEGFA—Signaling by VEGF—IL6—osteoarthritis	0.00167	0.00167	CbGpPWpGaD
Gliclazide—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—osteoarthritis	0.00166	0.00166	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—HSPA5—osteoarthritis	0.00163	0.00163	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—SMAD3—osteoarthritis	0.00163	0.00163	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—TNF—osteoarthritis	0.00162	0.00162	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—IL1B—osteoarthritis	0.00157	0.00157	CbGpPWpGaD
Gliclazide—VEGFA—Axon guidance—MMP2—osteoarthritis	0.00156	0.00156	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—TIMP1—osteoarthritis	0.00155	0.00155	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.00153	0.00153	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—CXCL8—osteoarthritis	0.00153	0.00153	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—GSTO1—osteoarthritis	0.00149	0.00149	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	0.00147	0.00147	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—GSTO1—osteoarthritis	0.00144	0.00144	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—BGN—osteoarthritis	0.00144	0.00144	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—MMP1—osteoarthritis	0.00141	0.00141	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—BGN—osteoarthritis	0.0014	0.0014	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—TNF—osteoarthritis	0.0014	0.0014	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—LEP—osteoarthritis	0.00139	0.00139	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	0.00138	0.00138	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.00137	0.00137	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—PTGS2—osteoarthritis	0.00134	0.00134	CbGpPWpGaD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—TGFB1—osteoarthritis	0.00131	0.00131	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—IL6—osteoarthritis	0.00131	0.00131	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—COL9A2—osteoarthritis	0.0013	0.0013	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—FN1—osteoarthritis	0.00129	0.00129	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—COL9A1—osteoarthritis	0.00126	0.00126	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.00125	0.00125	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—IL1B—osteoarthritis	0.00124	0.00124	CbGpPWpGaD
Gliclazide—VEGFA—Axon guidance—MMP9—osteoarthritis	0.00117	0.00117	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—TNF—osteoarthritis	0.00114	0.00114	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—IGF1—osteoarthritis	0.00113	0.00113	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—IL6—osteoarthritis	0.00113	0.00113	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—MMP2—osteoarthritis	0.00111	0.00111	CbGpPWpGaD
Gliclazide—ALB—Platelet degranulation—TGFB1—osteoarthritis	0.00104	0.00104	CbGpPWpGaD
Gliclazide—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoarthritis	0.000994	0.000994	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—IL6—osteoarthritis	0.000917	0.000917	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—TNF—osteoarthritis	0.000902	0.000902	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—FN1—osteoarthritis	0.000881	0.000881	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—BMP2—osteoarthritis	0.000862	0.000862	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—IL6—osteoarthritis	0.000857	0.000857	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—HSPA5—osteoarthritis	0.00084	0.00084	CbGpPWpGaD
Gliclazide—ALB—Metabolism—FMOD—osteoarthritis	0.000836	0.000836	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—MMP9—osteoarthritis	0.000836	0.000836	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—TIMP1—osteoarthritis	0.0008	0.0008	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—IGF1—osteoarthritis	0.000772	0.000772	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—FMOD—osteoarthritis	0.000751	0.000751	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—IL6—osteoarthritis	0.000728	0.000728	CbGpPWpGaD
Gliclazide—VEGFA—Axon guidance—IL6—osteoarthritis	0.000727	0.000727	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—TGFB1—osteoarthritis	0.000689	0.000689	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—FMOD—osteoarthritis	0.000685	0.000685	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PTGES—osteoarthritis	0.000682	0.000682	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—TGFB1—osteoarthritis	0.000676	0.000676	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—TNF—osteoarthritis	0.000643	0.000643	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PTGES—osteoarthritis	0.000612	0.000612	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—MMP3—osteoarthritis	0.000598	0.000598	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PTGES—osteoarthritis	0.000558	0.000558	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—SMAD3—osteoarthritis	0.000541	0.000541	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—IL6—osteoarthritis	0.000519	0.000519	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—MMP1—osteoarthritis	0.000497	0.000497	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GSTO1—osteoarthritis	0.00048	0.00048	CbGpPWpGaD
Gliclazide—ALB—Metabolism—BGN—osteoarthritis	0.000465	0.000465	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoarthritis	0.000463	0.000463	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—LEP—osteoarthritis	0.000462	0.000462	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—FN1—osteoarthritis	0.000454	0.000454	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—ESR1—osteoarthritis	0.000442	0.000442	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—FN1—osteoarthritis	0.000436	0.000436	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GSTO1—osteoarthritis	0.000431	0.000431	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—BGN—osteoarthritis	0.000418	0.000418	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—PTGS2—osteoarthritis	0.000415	0.000415	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—PTGS2—osteoarthritis	0.000402	0.000402	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—IGF1—osteoarthritis	0.000398	0.000398	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GSTO1—osteoarthritis	0.000393	0.000393	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IGF1—osteoarthritis	0.000382	0.000382	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—BGN—osteoarthritis	0.000381	0.000381	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CXCL8—osteoarthritis	0.000307	0.000307	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.0003	0.0003	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—MMP9—osteoarthritis	0.000278	0.000278	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.00027	0.00027	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.000246	0.000246	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—TGFB1—osteoarthritis	0.000238	0.000238	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TGFB1—osteoarthritis	0.000229	0.000229	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IL6—osteoarthritis	0.000173	0.000173	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PTGS2—osteoarthritis	0.000134	0.000134	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PTGS2—osteoarthritis	0.00012	0.00012	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PTGS2—osteoarthritis	0.000109	0.000109	CbGpPWpGaD
